Choledochoduodenostomy continues to be a safe alternative for biliary reconstruction in deceased-donor liver transplantation

Am J Surg. 2022 Dec;224(6):1398-1402. doi: 10.1016/j.amjsurg.2022.10.032. Epub 2022 Oct 17.

Abstract

Debate continues as to whether choledochoduodenostomy (CDD) can be used instead of Roux-en-Y choledochojejunostomy (CDJ) when duct-to-duct (DTD) is not an option. We hypothesized that CDD and CDJ had similar rates of complications. All deceased-donor liver transplantations from September 2011 to March 2020 were categorized by biliary reconstruction. Primary outcomes were bleeding, bile leak, anastomotic stricture, and cholangitis. Of the 1,086 patients, 812 (74.8%) received a DTD; 225 (20.7%) received a CDD; and 49 (4.5%) received a CDJ. Cholangitis was significantly higher in CDJ compared to DTD and CDD (26.5% vs 6% vs 13.8%, p < 0.0001). When controlling for significant confounders, CDJ had 10.2 higher odds of cholangitis (95% CI 4.4-23.2) compared to DTD, and 3.3 higher odds compared to CDD (95% CI 1.4-7.8). When compared to DTD, CDJ and CDD had significantly lower odds of stricture. CDD continues to be a safe alternative for biliary reconstruction in deceased-donor liver transplantation.

Keywords: Biliary anastomosis; Choledochoduodenostomy; Choledochojejunostomy; Duct-to-duct; Liver transplantation.

MeSH terms

  • Anastomosis, Roux-en-Y
  • Bile Ducts / surgery
  • Choledochostomy
  • Humans
  • Liver Transplantation*
  • Living Donors